2D

Inspire Medical Systems IncFRA Inspire Medical Stock Report

Last reporting period 30 Sep, 2024

Updated 12 Nov, 2024

Last price

Market cap $B

6.195

Middle

Exchange

XFRA - Deutsche Boerse AG

2DR.F Stock Analysis

2D

Uncovered

Inspire Medical Systems Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

98/100

Moderate score

Market cap $B

6.195

Dividend yield

Shares outstanding

29.048 B

Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. The company is headquartered in Golden Valley, Minnesota and currently employs 755 full-time employees. The company went IPO on 2018-05-03. The firm is focused on the development and commercialization of invasive solutions for patients with obstructive sleep apnea (OSA). The obstructive sleep apnea device that treats the root cause of sleep apnea by working inside the body with the patient’s natural breathing process. The firm has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The firm sells its system to the hospitals and ambulatory surgery centers (ASCs) in the United States and in select countries in Europe through a direct sales organization. The firm sells its Inspire system in Japan and Singapore through distributors.

View Section: Eyestock Rating